GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ferozsons Laboratories Ltd (KAR:FEROZ) » Definitions » YoY EPS Growth

Ferozsons Laboratories (KAR:FEROZ) YoY EPS Growth : 48.06% (As of Mar. 2025)


View and export this data going back to 1960. Start your Free Trial

What is Ferozsons Laboratories YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Ferozsons Laboratories's YoY EPS Growth for the quarter that ended in Mar. 2025 was 48.06%.

Ferozsons Laboratories's Earnings per Share (Diluted) for the three months ended in Mar. 2025 was ₨4.59.


Ferozsons Laboratories YoY EPS Growth Historical Data

The historical data trend for Ferozsons Laboratories's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ferozsons Laboratories YoY EPS Growth Chart

Ferozsons Laboratories Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 107.71 181.40 -37.39 -63.08 151.92

Ferozsons Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 269.05 3,114.29 -16.20 47.86 48.06

Ferozsons Laboratories YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Ferozsons Laboratories's YoY EPS Growth for the fiscal year that ended in Jun. 2024 is calculated as:

YoY EPS Growth (A: Jun. 2024 )
=(Earnings per Share (Diluted) (A: Jun. 2024 )-Earnings per Share (Diluted) (A: Jun. 2023 ))/ | Earnings per Share (Diluted) (A: Jun. 2023 ) |
=(15.72-6.24)/ | 6.24 |
=151.92 %

Ferozsons Laboratories's YoY EPS Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY EPS Growth (Q: Mar. 2025 )
=(Earnings per Share (Diluted) (Q: Mar. 2025 )-Earnings per Share (Diluted) (Q: Mar. 2024 )) / | Earnings per Share (Diluted) (Q: Mar. 2024 )) |
=(4.59-3.1)/ | 3.1 |
=48.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ferozsons Laboratories YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Ferozsons Laboratories's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Ferozsons Laboratories Business Description

Traded in Other Exchanges
N/A
Address
5.K.M - Sunder Raiwind Road, Lahore, PB, PAK
Ferozsons Laboratories Ltd is a pharmaceutical company. It is engaged in the import, manufacture, and sale of pharmaceuticals products and medical devices. The company operates in the therapeutic areas of dermatology, anti-infective treatments, gastroenterology, hepatology, cardiology, and oncology. It manufactures tablets, capsules, syrups, suspensions, creams, and ointments. It operates in three segments namely Ferozsons; BF Biosciences; and Others. The group sells its products in Pakistan and internationally, of which the majority of the revenue is generated from the sales made in Pakistan.

Ferozsons Laboratories Headlines

No Headlines